Prosecution Insights
Last updated: August 17, 2026

Examiner: BUCKMASTER, MARLENE VRENI

Tech Center 1600 • Art Units: 1671 1672

This examiner grants 29% of resolved cases

Performance Statistics

28.6%
Allow Rate
-31.4% vs TC avg
92
Total Applications
+77.1%
Interview Lift
1347
Avg Prosecution Days
Based on 28 resolved cases, 2023–2026

Rejection Statute Breakdown

6.7%
§101 Eligibility
15.2%
§102 Novelty
33.3%
§103 Obviousness
33.9%
§112 Clarity

Currently Pending Office Actions

App #TitleStatusAssignee
17925920 CORONAVIRUS ANTIGEN COMPOSITIONS AND THEIR USES Final Rejection Flagship Pioneering Innovations VI, LLC
18022050 COMPOSITION FOR DIAGNOSING INFECTIOUS DISEASES COMPRISING AGENT FOR MEASURING EXPRESSION LEVEL OF SREBP2 Final Rejection KYUNGPOOK NATIONAL UNIVERSITY INDUSTRY-ACADEMIC COOPERATION FOUNDATION
17631439 TARGETED EXOSOME BASED ON RBD REGION OF SARS-COV-2 S PROTEIN AND PREPARATION METHOD THEREOF Non-Final OA SOOCHOW UNIVERSITY
17594349 A METHOD OF IDENTIFYING A FLAVIVIRUS INFECTION, AND RELATED PEPTIDES, KITS AND COMPOSITIONS Non-Final OA Agency for Science, Technology and Research

Facing This Examiner?

IP Author analyzes examiner patterns and generates tailored response strategies with the highest chance of allowance.

Build Your Strategy

Sign in with your work email

Enter your email to receive a magic link. No password needed.

Personal email addresses (Gmail, Yahoo, etc.) are not accepted.

Free tier: 3 strategy analyses per month